AiCuris Anti-infective Cures GmbH
http://www.aicuris.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From AiCuris Anti-infective Cures GmbH
Finance Watch: FibroGen, Amarin And Others Downsize To Survive
Restructuring Edition: FibroGen follows its clinical setback with a 32% reduction in force, cutting 104 jobs. Also, Amarin named a new CEO, but cut all US sales and 30% of non-sales US roles, and 9 Meters is headed for dissolution after Chapter 7 bankruptcy, while several others seek strategic alternatives.
European COVID-19 Project An ‘Unprecedented’ Exercise In Cooperation
Repurposed drugs, new compounds and neutralizing antibodies are among the targets of a new collaborative venture supported by Europe’s Innovative Medicines Initiative.
Coronavirus Update: Sanofi and GSK ‘Happy To Lose’ COVID-19 Vaccine Race
Heads of vaccines development at partners GSK and Sanofi:“This is not a sprint, it’s a marathon.”
Royalty Pharma Nears Biopharma Record Take With $2.18bn IPO
Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice